ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
Symptom burden in patients with hematologic malignancies and its influencing factors.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate global, physical, and psychological symptom burden in patients with hematologic malignancies and its influencing factors.
methodsThis study employed convenience sampling. Sociodemographic data and standardized scales (Memorial Symptom Assessment Scale, Cancer Coping Modes Questionnaire, and Social Support Rate Scale) were collected. Statistical analyses included Kruskal-Wallis H test, Mann-Whitney U test, Spearman correlation, and generalized linear modeling.
findingsA total of 501 questionnaires were distributed, and 405 valid questionnaires were finally recovered. Results showed an Memorial Symptom Assessment Scale total score of 0.36 (0.16, 0.67), with physical symptom dimension score 0.44 (0.17, 0.86) significantly exceeding psychological symptom dimension score 0.28 (0, 0.67). Lack of energy was the most prevalent (58.52%) and burdensome symptom. Generalized linear regression identified female gender (β = 0.096, p = 0.008), fewer treatment sessions (β = - 0.003, p = 0.028), resignation coping (β = 0.042, p < 0.000), and fantasy coping (β = 0.029, p < 0.001) as significant predictors of higher overall burden. Compared to other malignancy types, leukemia(β = -0.244, p = 0.001), lymphoma (β = - 0.282, p < 0.000), myelodysplastic syndrome (β = - 0.189, p = 0.034), and multiple myeloma (β = - 0.32; p < 0.000) demonstrated protective effects against symptom burden.
conclusionPatients experience a significant burden of physical symptoms during hospitalization, and the burden of psychological symptoms in patients may be underestimated. Therefore, it is crucial to construct and apply a more accurate assessment system of psychological symptom burden. Additionally, establishing a standardized symptom burden screening mechanism is recommended to effectively identify high-risk patients and enable immediate interventions for high-burden symptoms.
Indexed as
Identifiers
41724859What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.